
DolPHIN 2
@uoldolphin2
International collaboration investigating the safety and efficacy of dolutegravir in pregnant HIV+ women & their neonates vimeo.com/521856547 #PMTCT
ID: 826436055062736896
http://www.dolphin2.org 31-01-2017 14:24:44
431 Tweet
277 Followers
115 Following


Infectious Diseases Institute, Makerere University invites you to the 5th #IDIScienceFair2024, a premier event for researchers, scientists, and key stakeholders in infectious diseases and emerging health threats to exchange knowledge and ideas on strengthening Africa’s health systems and improving healthcare outcomes

Day one of The Drug Optimisation in LMIC of Pregnant HIV Women & Their INfants: Temporary Switch to CAB/RPV Long-Acting Injections (DolPHIN-3) study consortium meeting at University of Liverpool #DOLPHIN3 #AtTheEquatorUG ThokoMalaba Helen Reynolds Jacqueline Kyeyune Mr.MAGOOLA Paul Gonza



Meet the fanya dudkin team discussing safely transitioning women from injectable ART to oral ART





Congratulations to HIV Drug Interactions

This #WorldAIDSDay2024 theme is Take the rights path: My health, my right! We stand with World Health Organization (WHO) as we call for health care workers to deliver care that is kind, respectful of human rights and without stigma.




Rapid summary of this paper and 'call to action'. Only one LAI ART regimen is licensed. Most of the world cannot access it. ViiV Healthcare have ensured equitable access to CAB, as they did for DTG. Companies should be held to their promises. 'Medicines only help if people can get them'






Without U.S. funding and no alternative funding is secured, UNAIDS Global estimates that there would be an additional: ➡️350,000 new HIV infections in children ➡️8.7 million new HIV adult infections ➡️6.3 million AIDS-related deaths Read more 👉hivpreventioncoalition.unaids.org/en/news/global…
